Loading…

Micelle‐enhanced spectrofluorimetric determination of diphenhydramine: application to human plasma and its simultaneous determination with naproxen in pharmaceutical tablets

Two simple and sensitive spectrofluorimetric methods were developed and validated for determination of diphenhydramine. The use of sodium dodecyl sulfate surfactant at pH 7 enhances the fluorescence intensity of diphenhydramine at 286 nm (method I) enabling its nanodetermination in biological sample...

Full description

Saved in:
Bibliographic Details
Published in:Luminescence (Chichester, England) England), 2021-05, Vol.36 (3), p.733-741
Main Authors: Hammad, Sherin F., El‐Khateeb, Basma Z., El‐Malla, Samah F.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Two simple and sensitive spectrofluorimetric methods were developed and validated for determination of diphenhydramine. The use of sodium dodecyl sulfate surfactant at pH 7 enhances the fluorescence intensity of diphenhydramine at 286 nm (method I) enabling its nanodetermination in biological samples with mean per cent recovery ± SD of 100.33 ± 1.519. Method I was validated according to ICH‐Q2R1 guidelines and was successfully applied for determination of diphenhydramine in pharmaceutical dosage form and spiked human plasma in the concentration ranges 0.1–4.0 μg/mL and 0.2–1.0 μg/mL, respectively. Method I acted as a basis for the development of a first derivative synchronous spectrofluorimetry (method II) for simultaneous analysis of diphenhydramine and naproxen using a zero‐crossing approach. Method II determines both drugs with linearity ranges of 0.05–3.0 μg/mL and 0.1–0.9 μg/mL for diphenhydramine and naproxen, respectively. The developed method was applied for the simultaneous determination of both drugs in their laboratory‐prepared mixtures containing all expected excipients. Method II determines both drugs with a mean percent recovery ± SD of 100.56 ± 0.891 and 100.20 ± 1.125 for diphenhydramine and naproxen, respectively. The method was statistically compared with a reported method using Student's t‐ and F‐ tests, and no significant differences were observed. • The first micellar enhancement spectrofluorimetric method for determination of diphenhydramine. • The first spectrofluorimetric method for the simultaneous determination of diphenhydramine and naproxen. • No derivatization procedures, which suffer from long reaction times, high cost of derivatizing agents and complicated procedures. • Fluorescence enhancement by micelle formation is one of the most simple and cost‐effective approaches to enhance the weak native fluorescence of samples.
ISSN:1522-7235
1522-7243
DOI:10.1002/bio.3996